Payments To Acquire In Process Research And Development, Other
Viatris Payments To Acquire In Process Research And Development, Other increased by 83.2% to -$6.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 60.0%, from -$15.00M to -$6.00M. Over 2 years (FY 2022 to FY 2024), Payments To Acquire In Process Research And Development, Other shows an upward trend with a -48.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher spending indicates a focus on future growth through external innovation, whereas lower spending may suggest a reliance on internal pipelines.
Detailed definition
This represents cash outflows specifically allocated to the acquisition of research and development projects that are cu...
Peer comparison
Essential for pharmaceutical and biotech companies; peers vary based on their 'buy vs. build' R&D strategy.
operating_payments_to_acquire_in_process_research_and_de_95ae93Historical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$11.60M | -$11.60M | -$11.60M | -$11.60M | $0.00 | -$10.20M | -$1.10M | -$89.10M | $5.20M | $7.50M | $0.00 | -$25.00M | -$15.00M | -$35.80M | -$6.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +100.0% | — | +89.2% | <-999% | +105.8% | +44.2% | -100.0% | — | +40.0% | -138.7% | +83.2% |
| YoY Change | — | — | — | — | +100.0% | +12.1% | +90.5% | -668.1% | — | +173.5% | +100.0% | +71.9% | -388.5% | -43.2% | +60.0% |
Payments To Acquire In Process Research And Development, Other at Other Companies
Frequently Asked Questions
- What is Viatris's payments to acquire in process research and development, other?
- Viatris (VTRS) reported payments to acquire in process research and development, other of -$6.00M in Q1 2026.
- How has Viatris's payments to acquire in process research and development, other changed year-over-year?
- Viatris's payments to acquire in process research and development, other increased by 60.0% year-over-year, from -$15.00M to -$6.00M.
- What is the long-term trend for Viatris's payments to acquire in process research and development, other?
- Over 2 years (2022 to 2024), Viatris's payments to acquire in process research and development, other has grown at a -48.5% compound annual growth rate (CAGR), from -$46.40M to -$12.30M.
- What does payments to acquire in process research and development, other mean?
- Cash spent to buy ongoing research projects from other companies.